Gilles Pagès

14.2k total citations · 2 hit papers
173 papers, 11.3k citations indexed

About

Gilles Pagès is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gilles Pagès has authored 173 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 66 papers in Oncology and 46 papers in Cancer Research. Recurrent topics in Gilles Pagès's work include Angiogenesis and VEGF in Cancer (37 papers), Cancer, Hypoxia, and Metabolism (28 papers) and Melanoma and MAPK Pathways (14 papers). Gilles Pagès is often cited by papers focused on Angiogenesis and VEGF in Cancer (37 papers), Cancer, Hypoxia, and Metabolism (28 papers) and Melanoma and MAPK Pathways (14 papers). Gilles Pagès collaborates with scholars based in France, Monaco and United States. Gilles Pagès's co-authors include Jacques Pouysségur, Julie Milanini, Sylvain Meloche, Patrick Auberger, Gilles L’Allemain, Jean‐Claude Chambard, Philippe Lenormand, Anne Brunet, Clotilde Gimond and Francesc Viñals and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Gilles Pagès

173 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.

1993 899 citations Gilles Pagès, Jacques Pouysségur et al. profile →
Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice

1999 544 citations Gilles Pagès, Jacques Pouysségur et al. profile →

Peers

Countries citing papers authored by Gilles Pagès

Since Specialization

Citations

This map shows the geographic impact of Gilles Pagès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Pagès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Pagès more than expected).

Fields of papers citing papers by Gilles Pagès

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Pagès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Pagès. The network helps show where Gilles Pagès may publish in the future.

Co-authorship network of co-authors of Gilles Pagès

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Pagès. A scholar is included among the top collaborators of Gilles Pagès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Pagès. Gilles Pagès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma 2025 ·Cancer Research ·(unknown), Umakant Sahu, Julien Parola, (unknown), Valérie Vial, Jérôme Durivault, (unknown), Yann Cormerais, Clément Molina, Aurore Gouraud, Gilles Pagès, Issam Ben‐Sahra, Sandy Giuliano	1
2	A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma 2023 ·Molecular Oncology ·Christopher Montemagno, Jérôme Durivault, (unknown), Maeva Dufies, Valérie Vial, Xingkang He, Damien Ambrosetti, (unknown), Sylvie Négrier, Jean‐Christophe Bernhard, Delphine Borchiellini, Yihai Cao, Gilles Pagès	5
3	New Phenylspirodrimanes from the Sponge-Associated Fungus Stachybotrys chartarum MUT 3308 2023 ·Marine Drugs ·(unknown), (unknown), Elena Bovio, Olivia Rastoin, Maeva Dufies, Fabien Fontaine‐Vive, Elisabeth Taffin de Givenchy, (unknown), Gilles Pagès, Giovanna Cristina Varese, Mohamed Mehiri	8
4	Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine? 2021 ·International Journal of Molecular Sciences ·Christopher Montemagno, Shamir Cassim, (unknown), Jérôme Durivault, Marc Faraggi, Gilles Pagès	12
5	VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells 2020 ·Communications Biology ·(unknown), (unknown), (unknown), Rita Hanna, Jérôme Durivault, (unknown), (unknown), (unknown), (unknown), Fanny Burel‐Vandenbos, (unknown), Daniel Williamson, Steven C. Clifford, (unknown), J. Doyen, Vincent Picco, Sonia Martial, Gilles Pagès	12
6	Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma 2019 ·Journal of Cellular and Molecular Medicine ·Yann Cormerais, (unknown), (unknown), Sandy Giuliano, Éric Tambutté, Hitoshi Endou, Michael F. Wempe, Gilles Pagès, Jacques Pouysségur, Vincent Picco	37
7	ERK1 as a Therapeutic Target for Dendritic Cell Vaccination against High-Grade Gliomas 2016 ·Molecular Cancer Therapeutics ·Min‐Chi Ku, (unknown), Ivo Bendix, Andreas Pohlmann, Helmar Waiczies, Tim Prozorovski, (unknown), (unknown), Gilles Pagès, Susanne A. Wolf, Helmut Kettenmann, Wolfgang Uckert, Thoralf Niendorf, Sonia Waiczies	7
8	Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins 2016 ·Cancer Research ·Edward Hitti, Tala Bakheet, (unknown), Walid Moghrabi, (unknown), Maha Ali Alghamdi, Maher Al‐Saif, Mohamed M. Shoukri, András Lánczky, Renaud Grépin, Balázs Győrffy, Gilles Pagès, Khalid S.A. Khabar	63
9	VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing 2015 ·Methods in molecular biology ·Mélanie Guyot, Gilles Pagès	28
10	Control of Pro-Angiogenic Cytokine mRNA Half-Life in Cancer: The Role of AU-Rich Elements and Associated Proteins 2014 ·Journal of Interferon & Cytokine Research ·Paola Griseri, Gilles Pagès	28
11	The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma 2013 ·Cancer Research ·Renaud Grépin, Mélanie Guyot, Sandy Giuliano, (unknown), Damien Ambrosetti, Emmanuel Chamorey, Jean‐Yves Scoazec, Sylvie Négrier, Hélène Simonnet, Gilles Pagès	80
12	Cutting Edge: Extracellular Signal-Related Kinase Is Not Required for Negative Selection of Developing T Cells 2009 ·The Journal of Immunology ·Maureen A. McGargill, Irene L. Ch’en, Carol D. Katayama, Gilles Pagès, Jacques Pouysségur, Stephen Μ. Hedrick	25
13	NOD2: a potential target for regulating liver injury 2008 ·Laboratory Investigation ·Mathilde Body–Malapel, Sébastien Dharancy, Dominique Berrebi, Alexandre Louvet, Jean‐Pierre Hugot, Dana J. Philpott, Marco Giovannini, Fabrice Chareyre, Gilles Pagès, (unknown), Stephen E. Girardin, Irène Garcia, Sylvie Hudault, Filoména Conti, Philippe J. Sansonetti, Mathias Chamaillard, Pierre Desreumaux, Laurent Dubuquoy, Philippe Mathurin	36
14	The Role of ERK Mitogen-Activated Protein Kinase (MAPK) in Lens Development 2007 ·Investigative Ophthalmology & Visual Science ·Lixing W. Reneker, Michael L. Robinson, M Ogata, Hideki Sanjo, Gilles Pagès	1
15	A Novel Role for IκB Kinase (IKK) α and IKKβ in ERK-Dependent Up-Regulation of MUC5AC Mucin Transcription by Streptococcus pneumoniae 2007 ·The Journal of Immunology ·Un‐Hwan Ha, Jae Hyang Lim, Hirofumi Jono, Tomoaki Koga, Amit Srivastava, Richard Malley, Gilles Pagès, Jacques Pouysségur, Jiandong Li	61
16	Tristetraprolin Inhibits Ras-dependent Tumor Vascularization by Inducing Vascular Endothelial Growth Factor mRNA Degradation 2007 ·Molecular Biology of the Cell ·Khadija Essafi‐Benkhadir, Cercina Onesto, (unknown), Christoph Moroni, Gilles Pagès	85
17	ERK1 plays a critical protective role against N‐methyl‐D‐aspartate‐induced retinal injury 2007 ·Journal of Neuroscience Research ·Toru Nakazawa, Masahiko Shimura, Morin Ryu, Kohji Nishida, Gilles Pagès, Jacques Pouysségur, Shogo Endo	40
18	Differential Regulation of Tumor Angiogenesis by Distinct ErbB Homo- and Heterodimers 2002 ·Molecular Biology of the Cell ·Lily Yen, Naciba Benlimame, (unknown), Dingzhang Xiao, Taiqi Wang, Ala‐Eddin Al Moustafa, Hiroyasu Esumi, Julie Milanini, Nancy E. Hynes, Gilles Pagès, Moulay A. Alaoui‐Jamali	114
19	Signaling Angiogenesis via p42/p44 MAP Kinase Cascade 2000 ·Annals of the New York Academy of Sciences ·Gilles Pagès, Julie Milanini, Darren E. Richard, Edurne Berra, Emmanuel Gothié, Francesc Viñals, Jacques Pouysségur	119
20	The Mouse p44 Mitogen-activated Protein Kinase (Extracellular Signal-regulated Kinase 1) Gene 1995 ·Journal of Biological Chemistry ·Gilles Pagès, E. Richard Stanley, Maude Le Gall, Anne Brunet, Jacques Pouysségur	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact